The most notable mutations that can be targeted in PCa include gene products that regulate DNA repair through homologous recombination (HR), such as BRCA1, BRCA2, ATM, PALB2, CHEK2 and HOXB13 [9,15,16,17]. The gene discussed is CHEK2; the disease is posterior cortical atrophy.